Venus Concept, Inc. (VERO)
0.3105
0.00 (0.00%)
USD |
OTCM |
Apr 07, 16:00
Venus Concept Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 07, 2026 | 27.77M |
| April 06, 2026 | 27.77M |
| April 02, 2026 | 27.76M |
| April 01, 2026 | 27.75M |
| March 31, 2026 | 27.85M |
| March 30, 2026 | 27.77M |
| March 27, 2026 | 27.82M |
| March 26, 2026 | 27.79M |
| March 25, 2026 | 27.77M |
| March 24, 2026 | 27.84M |
| March 23, 2026 | 27.85M |
| March 20, 2026 | 27.82M |
| March 19, 2026 | 27.84M |
| March 18, 2026 | 27.77M |
| March 17, 2026 | 27.85M |
| March 16, 2026 | 27.77M |
| March 13, 2026 | 27.92M |
| March 12, 2026 | 27.90M |
| March 11, 2026 | 27.88M |
| March 10, 2026 | 27.90M |
| March 09, 2026 | 27.88M |
| March 06, 2026 | 27.92M |
| March 05, 2026 | 28.03M |
| March 04, 2026 | 27.94M |
| March 03, 2026 | 27.90M |
| Date | Value |
|---|---|
| March 02, 2026 | 27.85M |
| February 27, 2026 | 27.77M |
| February 26, 2026 | 27.81M |
| February 25, 2026 | 27.81M |
| February 24, 2026 | 27.85M |
| February 23, 2026 | 27.85M |
| February 20, 2026 | 27.87M |
| February 19, 2026 | 27.88M |
| February 18, 2026 | 28.11M |
| February 17, 2026 | 28.09M |
| February 13, 2026 | 27.94M |
| February 12, 2026 | 27.95M |
| February 11, 2026 | 28.16M |
| February 10, 2026 | 28.29M |
| February 09, 2026 | 28.68M |
| February 06, 2026 | 29.32M |
| February 05, 2026 | 29.39M |
| February 04, 2026 | 29.80M |
| February 03, 2026 | 29.56M |
| February 02, 2026 | 29.80M |
| January 30, 2026 | 29.56M |
| January 29, 2026 | 29.45M |
| January 28, 2026 | 29.65M |
| January 27, 2026 | 29.80M |
| January 26, 2026 | 30.08M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Hypertension Diagnostics, Inc. | -- |
| Avitar, Inc. | -- |
| Abbott Laboratories | 216.96B |
| AngioDynamics, Inc. | 474.40M |
| Alphatec Holdings, Inc. | 1.684B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -22.55M |
| Revenue (Quarterly) | 13.78M |
| Total Expenses (Quarterly) | 36.34M |
| EPS Diluted (Quarterly) | -12.14 |